GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands - Ownership and Business Overview

Life ScienceCompany

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands Ownership

Who owns GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands?

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is owned by Aspen Pharmacare Holdings. It was acquired on September 30, 2013.

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands Business Overview

Where is GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands headquartered?

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is headquartered in United Kingdom.

What sector is GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands in?

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is a life science company.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 192 acquisitions of life science companies in 2013, including 26 acquisitions by private equity firms, and 166 by strategics.

Acquired by Aspen Pharmacare Holdings Ltd. (Company) on 2013-09-30

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands

United Kingdom,

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is a specialised sterile production site which manufactures the Brands at Notre Dame de Bondeville, France . Arixtra and Fraxiparine/Fraxodi are made at a sterile site and the ability to manufacture steriles is globally recognised as a specialist activity resulting in limited possible competition. This is a factor further underlined by the increased complexity of the manufacturing process of Fraxiparine/Fraxodi due to the biological nature of the active pharmaceutical ingredients (“API”) used in their production.

Company Summary

SECTOR

Investor History
2013-09-30
Divestiture

700M GBP

Aspen Pharmacare

GSK

Subscribe to unlock this and 208,151
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.6K Private Equity Firms
201K M&A Transactions
204K Companies Involved in M&A
(Buyer, Seller, or Target)
3.6K M&A Advisors
(Investment Banks and Law Firms)
80K M&A Contacts
(PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands

Life Science Companies , United Kingdom Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United Kingdom Companies

Largest United Kingdom Companies , Acquisitive United Kingdom Companies , Recently Acquired United Kingdom Companies , Recently Sold United Kingdom Companies , Private United Kingdom Companies , Public United Kingdom Companies , Acquired United Kingdom Companies , PE Backed United Kingdom Companies